IndiaNorway Backed Elmentoz Research Secures Seed Funding to Revolutionize Animal Nutrition and Smart Feed Technology
Elmentoz Research Pvt. Ltd., a deep-tech biotechnology company specializing in precision animal health nutrition and smart feed solutions for poultry, aquaculture, and pet food, has successfully closed its first seed funding round with angel investors from India and Norway. This capital infusion will support the establishment of India’s largest BSF-based smart protein facility, capable of processing 2,000 MT per month of industrial byproducts through proprietary advanced automation technologies. The facility is scheduled to launch in January 2026, marking a major milestone in India’s sustainable feed and next-generation smart protein sector.
The funding accelerates Elmentoz’s mission to develop sustainable, next-generation biofeed solutions that reduce India’s reliance on imported functional feed additives, mitigate biosecurity risks—including antimicrobial resistance—and enhance farmer profitability. The company’s IP-driven innovation platform combines genomics, proteomics, advanced automation, and cGMP manufacturing to deliver AMP-fortified immune-smart premixes, smart protein formulations, and functional oil ingredients under its flagship product lines ELGROW and ELTIDE. These precision-nutrition solutions improve gut health, feed conversion efficiency, and disease resilience, effectively replacing antibiotic growth promoters (AGPs) with functional immuno-nutrition.
Key Uses of Seed Funding:
-
Scale India’s first advanced automated cGMP smart-protein manufacturing facility
-
Expand ELGROW and ELTIDE product portfolios
-
Advance antimicrobial peptide (AMP) technology and platform development
-
Strengthen strategic international partnerships
-
Grow research, manufacturing, and commercial teams to support rapid expansion
Dr. Jayashankar Das, Founder & CEO, stated:
“India must prioritize nutritional security alongside food security. Our insect protein and AMP platforms deliver consistent amino acid profiles, better gut health, and antibiotic-free performance across poultry, aquaculture, and pet segments. With genomics, proteomics, and cGMP manufacturing, we can replace AGPs with targeted functional feeds that are safer, smarter, and more resilient for farmers and feed manufacturers.”
Dr. Padmaja Mohanty, Co-Founder & CTO, added:
“Insects are nature’s most efficient bio-converters. At Elmentoz, they become drivers of sustainable protein security. This funding enables us to scale research to understand animal health mechanisms and translate insights into precision feed formulations. Sustainability isn’t a feature; it’s the operating system for the next decade of animal nutrition.”
Christen Hveem, angel investor from Norway, commented:
“Nutritional security is becoming a global priority. India, with innovators like Elmentoz, can emerge as a global leader in next-generation smart proteins and precision feed nutrition. Elmentoz is building a transformative platform that can shape the future of sustainable food systems.”
Elmentoz is poised to create India’s first research-driven insect protein line, unlocking a significant opportunity in the global insect-enabled feed industry and redefining sustainable animal nutrition for the coming decade.
